| Literature DB >> 35459801 |
Nicola Maffulli1,2,3, Nikolaos Gougoulias4,5, Gayle D Maffulli6, Francesco Oliva1, Filippo Migliorini7.
Abstract
The present study reports the outcomes of revision surgery using a Cincinnati incision with tendon debridement and calcaneoplasty for insertional Achilles tendinopathy (IAT) in a cohort of patients at 24-month follow-up. Patients undergoing revision surgery following failed previous surgery for IAT were prospectively recruited. Patients were assessed pre-operatively and at 3, 6,12 and 24 months. The Victorian Institute of Sport Assessment Scale for Achilles Tendinopathy (VISA-A), the EQ5D questionnaire and the visual analogue scale (VAS) were used for evaluation. Data from 33 patients with a mean age of 43.9 years old are reported. 27% (9 of 33 patients) were female. The left side was involved in 58% (19/33) of patients. No clinically relevant complications were reported in any of the patients. Most of subscales of EQ5D improved at last follow-up: Usual Activities (P = 0.01), Mobility (P = 0.03), Pain/Discomfort (P = 0.001), Thermometer (P = 0.04). No statistically significant change for the subscales Self-Care (P = 0.08) and Anxiety-Depression (P = 0.1) was evidenced. The VISA-A score improved significantly at last follow-up (P < 0.0001), as did the VAS score (P < 0.0001). These results indicated that a Cincinnati incision followed by tendon debridement and calcaneoplasty for revision surgery for IAT is feasible and reliable, achieving clinically relevant improvement in the VISA-A, EQ5D and VAS at 24 months follow-up.Entities:
Mesh:
Year: 2022 PMID: 35459801 PMCID: PMC9033808 DOI: 10.1038/s41598-022-10730-x
Source DB: PubMed Journal: Sci Rep ISSN: 2045-2322 Impact factor: 4.996
Figure 1Failed lateral open approach revised with Cincinnati incision.
Figure 2Failed lateral endoscopic approach revised with Cincinnati (right: pre-operative, left: 7 months post-operatively).
Figure 3Flow-chart of the enrolment process.
Demographic data of the included patients.
| Demographic at baseline | |
|---|---|
| Patients | 33 |
| Age | 43.9 ± 10.6 |
| Female | 27% (9/33) |
| Left side | 58% (19/33) |
| 1 | 45.5% (15/33) |
| 2 | 24.2% (8/33) |
| 3 | 15.2% (5/33) |
| 4 | 12.1% (4/33) |
| 5 | 0.0% (0/33) |
| 6 | 3.0% (1/33) |
Improvement of the EQ5D at the various follow-up appointments (*statistically significant following Bonferroni post-hoc correction).
| Endpoint | Values | Mean difference | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-operatively | 3-month | 6-month | 12-month | 24-month | Pre-operatively | 3–6 months | 6–12 months | 12–24 months | |
| EQ5D usual activities | 1.9 ± 0.5 | 1.4 ± 0.5 | 1.4 ± 0.6 | 1.2 ± 0.5 | 1.3 ± 0.6 | − 0.53 ( | 0.02 ( | − 0.20 ( | 0.07 ( |
| EQ5D anxiety-depression | 1.4 ± 0.5 | 1.2 ± 0.4 | 1.1 ± 0.3 | 1.2 ± 0.4 | 1.2 ± 0.4 | − 0.21 ( | 0.09 ( | 0.06 ( | 0.01 ( |
| EQ5D mobility | 1.8 ± 0.4 | 1.4 ± 0.5 | 1.3 ± 0.5 | 1.2 ± 0.4 | 1.2 ± 0.4 | − 0.43 ( | − 0.14 ( | − 0.04 ( | 0.01 ( |
| EQ5D pain/discomfort | 2.1 ± 0.5 | 1.7 ± 0.6 | 1.5 ± 0.5 | 1.4 ± 0.5 | 1.5 ± 0.5 | − 0.40 ( | − 0.21 ( | − 0.14 ( | 0.08 ( |
| EQ5D self-care | 1.1 ± 0.4 | 1.1 ± 0.3 | 1.0 ± 0.0 | 1.0 ± 0.0 | 1.0 ± 0.0 | − 0.07 ( | − 0.07 ( | − 0.00 ( | − 0.00 ( |
| EQ5D thermometer scale | 62.1 ± 25.1 | 75.8 ± 23.6 | 80.8 ± 18.1 | 82.6 ± 15.5 | 75.4 ± 18.2 | 13.77 ( | 5.01( | 1.86 ( | − 7.2 ( |
Improvement of the VISA-A and VAS scores at the various follow-up appointments (*statistically significant following Bonferroni post-hoc correction).
| Endpoint | Values | Mean difference | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Pre-operatively | 3-month | 6-month | 12-month | 24-month | Pre-3 months | 3–6 months | 6–12 months | 12–24 months | |
| VISA-A (%) | 39.7 ± 23 | 59.8 ± 25.9 | 66.6 ± 25.4 | 77.8 ± 25.3 | 74.5 ± 29.1 | 20.09 (P = 0.0001)* | 6.80 ( | 11.18 ( | − -.24 ( |
| VAS (%) | 64.4 ± 19.0 | 30.4 ± 28.6 | 21.3 ± 19.3 | 15.0 ± 21.0 | 13.6 ± 20.4 | − 33.99 ( | − 9.18 ( | − 6.26 ( | − 1.41 ( |